Loading…
Nonpharmacological management of neonatal abstinence syndrome: a review of the literature
Background: Infants with neonatal abstinence syndrome (NAS) experience withdrawal that occurs as a result of termination of placental opioid supply following delivery. Common symptoms include restlessness, tremors, agitation and gastrointestinal disturbances. Severe NAS is often treated using opioid...
Saved in:
| Published in: | The journal of maternal-fetal & neonatal medicine 2019-05, Vol.32 (10), p.1735-1740 |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c392t-217c3a58c2ee63ad778a40946c3be694de4a470c76436200849d1fbb238259173 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c392t-217c3a58c2ee63ad778a40946c3be694de4a470c76436200849d1fbb238259173 |
| container_end_page | 1740 |
| container_issue | 10 |
| container_start_page | 1735 |
| container_title | The journal of maternal-fetal & neonatal medicine |
| container_volume | 32 |
| creator | Ryan, Gareth Dooley, Joe Gerber Finn, Lianne Kelly, Len |
| description | Background: Infants with neonatal abstinence syndrome (NAS) experience withdrawal that occurs as a result of termination of placental opioid supply following delivery. Common symptoms include restlessness, tremors, agitation and gastrointestinal disturbances. Severe NAS is often treated using opioids and/or sedatives. Although commonly employed effectively in neonatal care, there is a lack of published information regarding nonpharmacological management of the NAS infant.
Objective: The purpose of this review was to summarize the current literature on nonpharmacological management of NAS.
Methods: A literature search of Medline and EMBASE was performed for articles published between 2000 and June 2107.
Results: Nonpharmacological management encompasses "environmental control", "feeding methods", "social integration", "soothing techniques" and "therapeutic modalities". Several interventions, including: breastfeeding, swaddling, rooming-in, environmental control and skin to skin contact have proven to be effective in managing NAS and should be incorporated into standard of care for this population (Level I-III Evidence). These interventions can be effective when offered in combination with pharmacological therapy, or as stand-alone therapy for less severe cases of NAS (Finnegan score |
| doi_str_mv | 10.1080/14767058.2017.1414180 |
| format | article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmed_primary_29207895</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>29207895</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-217c3a58c2ee63ad778a40946c3be694de4a470c76436200849d1fbb238259173</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRbK3-BCV_oHW_kt14UopfUPSiB0_LZDNpI8lu2U0t_fcmtPUoc5hheN4ZeAi5ZnTGqKa3TKpM0VTPOGVqxmRfmp6Q8bCfyjyVp4d5gEbkIsZvSjmTND0nI55zqnSejsnXm3frFYQWrG_8srbQJC04WGKLrkt8lTj0Drp-DUXsaofOYhJ3rgy-xbsEkoA_NW4Hslth0tQdBug2AS_JWQVNxKtDn5DPp8eP-ct08f78On9YTK3IeTflTFkBqbYcMRNQKqVB0lxmVhSY5bJECVJRqzIpMk6plnnJqqLgQvM0Z0pMSLq_a4OPMWBl1qFuIewMo2ZQZY6qzKDKHFT1uZt9br0pWiz_Ukc3PXC_B2pX-V7Q1oemNB3sGh-qAM7W0Yj_f_wCZvh4tg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Nonpharmacological management of neonatal abstinence syndrome: a review of the literature</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Ryan, Gareth ; Dooley, Joe ; Gerber Finn, Lianne ; Kelly, Len</creator><creatorcontrib>Ryan, Gareth ; Dooley, Joe ; Gerber Finn, Lianne ; Kelly, Len</creatorcontrib><description>Background: Infants with neonatal abstinence syndrome (NAS) experience withdrawal that occurs as a result of termination of placental opioid supply following delivery. Common symptoms include restlessness, tremors, agitation and gastrointestinal disturbances. Severe NAS is often treated using opioids and/or sedatives. Although commonly employed effectively in neonatal care, there is a lack of published information regarding nonpharmacological management of the NAS infant.
Objective: The purpose of this review was to summarize the current literature on nonpharmacological management of NAS.
Methods: A literature search of Medline and EMBASE was performed for articles published between 2000 and June 2107.
Results: Nonpharmacological management encompasses "environmental control", "feeding methods", "social integration", "soothing techniques" and "therapeutic modalities". Several interventions, including: breastfeeding, swaddling, rooming-in, environmental control and skin to skin contact have proven to be effective in managing NAS and should be incorporated into standard of care for this population (Level I-III Evidence). These interventions can be effective when offered in combination with pharmacological therapy, or as stand-alone therapy for less severe cases of NAS (Finnegan score <8).
Conclusions: Given the increasing body of evidence on its efficacy and ease of implementation, nonpharmacological treatment should universally be incorporated into standard of care for NAS.</description><identifier>ISSN: 1476-7058</identifier><identifier>EISSN: 1476-4954</identifier><identifier>DOI: 10.1080/14767058.2017.1414180</identifier><identifier>PMID: 29207895</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>Analgesics, Opioid - administration & dosage ; Analgesics, Opioid - adverse effects ; Conservative Treatment ; Female ; Humans ; Infant, Newborn ; Neonatal abstinence syndrome ; Neonatal Abstinence Syndrome - physiopathology ; Neonatal Abstinence Syndrome - therapy ; nonpharmacological ; opioid-related disorders ; Opioid-Related Disorders - complications ; Pregnancy ; Severity of Illness Index ; therapeutics</subject><ispartof>The journal of maternal-fetal & neonatal medicine, 2019-05, Vol.32 (10), p.1735-1740</ispartof><rights>2018 Informa UK Limited, trading as Taylor & Francis Group 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-217c3a58c2ee63ad778a40946c3be694de4a470c76436200849d1fbb238259173</citedby><cites>FETCH-LOGICAL-c392t-217c3a58c2ee63ad778a40946c3be694de4a470c76436200849d1fbb238259173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27900,27901</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29207895$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ryan, Gareth</creatorcontrib><creatorcontrib>Dooley, Joe</creatorcontrib><creatorcontrib>Gerber Finn, Lianne</creatorcontrib><creatorcontrib>Kelly, Len</creatorcontrib><title>Nonpharmacological management of neonatal abstinence syndrome: a review of the literature</title><title>The journal of maternal-fetal & neonatal medicine</title><addtitle>J Matern Fetal Neonatal Med</addtitle><description>Background: Infants with neonatal abstinence syndrome (NAS) experience withdrawal that occurs as a result of termination of placental opioid supply following delivery. Common symptoms include restlessness, tremors, agitation and gastrointestinal disturbances. Severe NAS is often treated using opioids and/or sedatives. Although commonly employed effectively in neonatal care, there is a lack of published information regarding nonpharmacological management of the NAS infant.
Objective: The purpose of this review was to summarize the current literature on nonpharmacological management of NAS.
Methods: A literature search of Medline and EMBASE was performed for articles published between 2000 and June 2107.
Results: Nonpharmacological management encompasses "environmental control", "feeding methods", "social integration", "soothing techniques" and "therapeutic modalities". Several interventions, including: breastfeeding, swaddling, rooming-in, environmental control and skin to skin contact have proven to be effective in managing NAS and should be incorporated into standard of care for this population (Level I-III Evidence). These interventions can be effective when offered in combination with pharmacological therapy, or as stand-alone therapy for less severe cases of NAS (Finnegan score <8).
Conclusions: Given the increasing body of evidence on its efficacy and ease of implementation, nonpharmacological treatment should universally be incorporated into standard of care for NAS.</description><subject>Analgesics, Opioid - administration & dosage</subject><subject>Analgesics, Opioid - adverse effects</subject><subject>Conservative Treatment</subject><subject>Female</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Neonatal abstinence syndrome</subject><subject>Neonatal Abstinence Syndrome - physiopathology</subject><subject>Neonatal Abstinence Syndrome - therapy</subject><subject>nonpharmacological</subject><subject>opioid-related disorders</subject><subject>Opioid-Related Disorders - complications</subject><subject>Pregnancy</subject><subject>Severity of Illness Index</subject><subject>therapeutics</subject><issn>1476-7058</issn><issn>1476-4954</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1Lw0AQhhdRbK3-BCV_oHW_kt14UopfUPSiB0_LZDNpI8lu2U0t_fcmtPUoc5hheN4ZeAi5ZnTGqKa3TKpM0VTPOGVqxmRfmp6Q8bCfyjyVp4d5gEbkIsZvSjmTND0nI55zqnSejsnXm3frFYQWrG_8srbQJC04WGKLrkt8lTj0Drp-DUXsaofOYhJ3rgy-xbsEkoA_NW4Hslth0tQdBug2AS_JWQVNxKtDn5DPp8eP-ct08f78On9YTK3IeTflTFkBqbYcMRNQKqVB0lxmVhSY5bJECVJRqzIpMk6plnnJqqLgQvM0Z0pMSLq_a4OPMWBl1qFuIewMo2ZQZY6qzKDKHFT1uZt9br0pWiz_Ukc3PXC_B2pX-V7Q1oemNB3sGh-qAM7W0Yj_f_wCZvh4tg</recordid><startdate>20190519</startdate><enddate>20190519</enddate><creator>Ryan, Gareth</creator><creator>Dooley, Joe</creator><creator>Gerber Finn, Lianne</creator><creator>Kelly, Len</creator><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20190519</creationdate><title>Nonpharmacological management of neonatal abstinence syndrome: a review of the literature</title><author>Ryan, Gareth ; Dooley, Joe ; Gerber Finn, Lianne ; Kelly, Len</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-217c3a58c2ee63ad778a40946c3be694de4a470c76436200849d1fbb238259173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Analgesics, Opioid - administration & dosage</topic><topic>Analgesics, Opioid - adverse effects</topic><topic>Conservative Treatment</topic><topic>Female</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Neonatal abstinence syndrome</topic><topic>Neonatal Abstinence Syndrome - physiopathology</topic><topic>Neonatal Abstinence Syndrome - therapy</topic><topic>nonpharmacological</topic><topic>opioid-related disorders</topic><topic>Opioid-Related Disorders - complications</topic><topic>Pregnancy</topic><topic>Severity of Illness Index</topic><topic>therapeutics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ryan, Gareth</creatorcontrib><creatorcontrib>Dooley, Joe</creatorcontrib><creatorcontrib>Gerber Finn, Lianne</creatorcontrib><creatorcontrib>Kelly, Len</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The journal of maternal-fetal & neonatal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ryan, Gareth</au><au>Dooley, Joe</au><au>Gerber Finn, Lianne</au><au>Kelly, Len</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nonpharmacological management of neonatal abstinence syndrome: a review of the literature</atitle><jtitle>The journal of maternal-fetal & neonatal medicine</jtitle><addtitle>J Matern Fetal Neonatal Med</addtitle><date>2019-05-19</date><risdate>2019</risdate><volume>32</volume><issue>10</issue><spage>1735</spage><epage>1740</epage><pages>1735-1740</pages><issn>1476-7058</issn><eissn>1476-4954</eissn><abstract>Background: Infants with neonatal abstinence syndrome (NAS) experience withdrawal that occurs as a result of termination of placental opioid supply following delivery. Common symptoms include restlessness, tremors, agitation and gastrointestinal disturbances. Severe NAS is often treated using opioids and/or sedatives. Although commonly employed effectively in neonatal care, there is a lack of published information regarding nonpharmacological management of the NAS infant.
Objective: The purpose of this review was to summarize the current literature on nonpharmacological management of NAS.
Methods: A literature search of Medline and EMBASE was performed for articles published between 2000 and June 2107.
Results: Nonpharmacological management encompasses "environmental control", "feeding methods", "social integration", "soothing techniques" and "therapeutic modalities". Several interventions, including: breastfeeding, swaddling, rooming-in, environmental control and skin to skin contact have proven to be effective in managing NAS and should be incorporated into standard of care for this population (Level I-III Evidence). These interventions can be effective when offered in combination with pharmacological therapy, or as stand-alone therapy for less severe cases of NAS (Finnegan score <8).
Conclusions: Given the increasing body of evidence on its efficacy and ease of implementation, nonpharmacological treatment should universally be incorporated into standard of care for NAS.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>29207895</pmid><doi>10.1080/14767058.2017.1414180</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1476-7058 |
| ispartof | The journal of maternal-fetal & neonatal medicine, 2019-05, Vol.32 (10), p.1735-1740 |
| issn | 1476-7058 1476-4954 |
| language | eng |
| recordid | cdi_pubmed_primary_29207895 |
| source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
| subjects | Analgesics, Opioid - administration & dosage Analgesics, Opioid - adverse effects Conservative Treatment Female Humans Infant, Newborn Neonatal abstinence syndrome Neonatal Abstinence Syndrome - physiopathology Neonatal Abstinence Syndrome - therapy nonpharmacological opioid-related disorders Opioid-Related Disorders - complications Pregnancy Severity of Illness Index therapeutics |
| title | Nonpharmacological management of neonatal abstinence syndrome: a review of the literature |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T02%3A46%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nonpharmacological%20management%20of%20neonatal%20abstinence%20syndrome:%20a%20review%20of%20the%20literature&rft.jtitle=The%20journal%20of%20maternal-fetal%20&%20neonatal%20medicine&rft.au=Ryan,%20Gareth&rft.date=2019-05-19&rft.volume=32&rft.issue=10&rft.spage=1735&rft.epage=1740&rft.pages=1735-1740&rft.issn=1476-7058&rft.eissn=1476-4954&rft_id=info:doi/10.1080/14767058.2017.1414180&rft_dat=%3Cpubmed_cross%3E29207895%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-217c3a58c2ee63ad778a40946c3be694de4a470c76436200849d1fbb238259173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/29207895&rfr_iscdi=true |